Literature DB >> 17526769

Longitudinal ultrastructure study of islet amyloid in the HIP rat model of type 2 diabetes mellitus.

Melvin R Hayden1, Poorna R Karuparthi, Camila Margarita Manrique, Guido Lastra, Javad Habibi, James R Sowers.   

Abstract

In 2004, the human islet amyloid polypeptide (HIP) rat model was created by transfecting the Sprague-Dawley rat with the human islet amyloid polypeptide (hIAPP)-amylin gene. The objective of this study is to utilize the transmission electron microscope to study the longitudinal cellular and extracellular morphological changes within the islets of this model at 4, 8, and 14 months of age. It has been previously demonstrated that the 2-, 5-, and 10-month HIP models have no diabetes, impaired fasting glucose, and diabetes, respectively. The 4-month HIP model (FBS 123 mg/dl) demonstrated an abundance of beta-cells and insulin secretory granules with significant pericapillary and inter-beta-cell islet amyloid deposition. The 8-month model (FBS 187 mg/dl) demonstrated extensive islet amyloid deposition and marked changes of beta-cell apoptosis. The 14-month-old model (FBS 244 mg/dl) demonstrated islet and beta-cell atrophy with even greater amounts of extracellular islet amyloid compared to the 4-month-old and 8-month-old models. Functional beta cells were sparse and were associated with intra islet adipose deposition. These findings of ultrastructure cellular and extracellular morphological longitudinal remodeling changes in this novel animal model of type 2 diabetes may provide investigators with a better understanding regarding the role of islet amyloid in human islet.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17526769

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  14 in total

1.  Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols.

Authors:  Ping Cao; Daniel P Raleigh
Journal:  Biochemistry       Date:  2012-03-21       Impact factor: 3.162

Review 2.  Attenuation of endocrine-exocrine pancreatic communication in type 2 diabetes: pancreatic extracellular matrix ultrastructural abnormalities.

Authors:  Melvin R Hayden; Kamlesh Patel; Javad Habibi; Deepa Gupta; Seema S Tekwani; Adam Whaley-Connell; James R Sowers
Journal:  J Cardiometab Syndr       Date:  2008

3.  The ability of rodent islet amyloid polypeptide to inhibit amyloid formation by human islet amyloid polypeptide has important implications for the mechanism of amyloid formation and the design of inhibitors.

Authors:  Ping Cao; Fanling Meng; Andisheh Abedini; Daniel P Raleigh
Journal:  Biochemistry       Date:  2010-02-09       Impact factor: 3.162

4.  Sensitivity of amyloid formation by human islet amyloid polypeptide to mutations at residue 20.

Authors:  Ping Cao; Ling-Hsien Tu; Andisheh Abedini; Olesya Levsh; Rehana Akter; Vadim Patsalo; Ann Marie Schmidt; Daniel P Raleigh
Journal:  J Mol Biol       Date:  2011-12-21       Impact factor: 5.469

5.  Characterization and validation of a streptozotocin-induced diabetes model in the vervet monkey.

Authors:  Kylie Kavanagh; David M Flynn; Chris Nelson; Li Zhang; Janice D Wagner
Journal:  J Pharmacol Toxicol Methods       Date:  2011-02-26       Impact factor: 1.950

6.  Pancreatic islet amyloidosis, beta-cell apoptosis, and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons.

Authors:  Rodolfo Guardado-Mendoza; Alberto M Davalli; Alberto O Chavez; Gene B Hubbard; Edward J Dick; Abraham Majluf-Cruz; Carlos E Tene-Perez; Lukasz Goldschmidt; John Hart; Carla Perego; Anthony G Comuzzie; Maria Elizabeth Tejero; Giovanna Finzi; Claudia Placidi; Stefano La Rosa; Carlo Capella; Glenn Halff; Amalia Gastaldelli; Ralph A DeFronzo; Franco Folli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-30       Impact factor: 11.205

7.  The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity.

Authors:  Fanling Meng; Andisheh Abedini; Annette Plesner; C Bruce Verchere; Daniel P Raleigh
Journal:  Biochemistry       Date:  2010-09-21       Impact factor: 3.162

8.  Treating hypertension while protecting the vulnerable islet in the cardiometabolic syndrome.

Authors:  Melvin R Hayden; James R Sowers
Journal:  J Am Soc Hypertens       Date:  2008-06-02

9.  Cardiorenal metabolic syndrome and diabetic cognopathy.

Authors:  M R Hayden; W A Banks; G N Shah; Z Gu; J R Sowers
Journal:  Cardiorenal Med       Date:  2013-11-29       Impact factor: 2.041

10.  Ultrastructure of islet microcirculation, pericytes and the islet exocrine interface in the HIP rat model of diabetes.

Authors:  Melvin R Hayden; Poorna R Karuparthi; Javad Habibi; Guido Lastra; Kamlesh Patel; Chetan Wasekar; Camila Margarita Manrique; Ugur Ozerdem; Sameer Stas; James R Sowers
Journal:  Exp Biol Med (Maywood)       Date:  2008-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.